Menu
| Description | The OUMS-23 cell line is a well-characterized, adherent human epithelial cell line established from the metastatic pericardial fluid of a male patient with Familial Adenomatous Polyposis (FAP) who developed colon adenocarcinoma |
| Product Name | OUMS-23 Cell Line |
| Cat.No | RWT-1247 |
| Product type | Colon carcinoma cell line |
| Product category | Tumor Cell Lines |
| Size | 1*10^6 cells/vial |
| Description | The OUMS-23 cell line is a well-characterized, adherent human epithelial cell line established from the metastatic pericardial fluid of a male patient with Familial Adenomatous Polyposis (FAP) who developed colon adenocarcinoma |
| Tissue | Colon |
| Species | Human |
| Gender | Male, 37 year-old |
| Disease | Colon carcinoma |
| Biosafety Level | BSL 1 |
| Morphology | Epithelial-like Adherent |
| Passage Ratio | A subcultivation ratio of 1:3 is recommended Medium Renewal: Twice per week |
| Culture Method | RPMI-1640+10%FBS |
| Quality Control | OUMS-23 Cell Line is negative for mycoplasma, bacteria, yeast, and fungi. |
| Shipping | Dry ice |
| Storage | Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use. |
| Warranty | OUMS-23 Cell Line is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA. |
| Disclaimers | Our OUMS-23 cell line is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen. |
| Applications | The OUMS-23 cell line is a human colon adenocarcinoma cell line widely used in colorectal cancer research, especially in studies involving FAP (familial adenomatous polyposis), APC mutations, tumor biology, and drug screening. |
If use of this product results in a scientific publication, it should be cited in the publication as: OUMS-23 Cell Line (Runtogen RWT-1247).
Inquire the OUMS-23 Cell Line by filling out the form below. We’ll get back to you within 24 hours with a quote.
Inquire the OUMS-23 Cell Line by filling out the form below. We’ll get back to you within 24 hours with a quote.
